Filter
561
Text search:
M.tuberculosis
Featured
Recommendations
61
New Publications
106
Language
Document type
No document type
398
Guidelines
70
Studies & Reports
41
Manuals
26
Strategic & Response Plan
11
Training Material
9
Situation Updates
4
Fact sheets
2
Countries / Regions
Western and Central Europe
43
Eastern Europe
25
India
23
Germany
14
Peru
10
Latin America and the Carribbean
10
Nepal
9
Argentina
9
Colombia
9
Ethiopia
8
Tanzania
8
Paraguay
7
Russia
7
Indonesia
6
South Africa
6
Mozambique
6
Ukraine
6
El Salvador
6
Uganda
5
Kenya
5
Cambodia
5
Bangladesh
5
Chile
5
Global
5
Zambia
4
Myanmar / Burma
4
Nigeria
3
Ghana
3
Malawi
3
Namibia
3
Asia
3
Tajikistan
3
Senegal
2
Philippines
2
Benin
2
Brazil
2
Ecuador
2
Bolivia
2
Uruguay
2
Sierra Leone
1
Liberia
1
Congo, Democratic Republic of
1
USA
1
Cameroon
1
Zimbabwe
1
South Sudan
1
Gambia
1
Eswatini/ Swaziland
1
Switzerland
1
Botswana
1
Lesotho
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Albania
1
Timor Leste/ East Timor
1
Estonia
1
Romania
1
Georgia
1
North America
1
Authors & Publishers
Publication Years
Category
Countries
171
Clinical Guidelines
67
Pharmacy & Technologies
10
Public Health
9
Women & Child Health
6
Capacity Building
5
Key Resources
3
Toolboxes
TB
377
HIV
35
AMR
16
NTDs
14
Polio
13
Ebola
12
Refugee
10
Rapid Response
7
Caregiver
5
COVID-19
3
Pharmacy
3
Natural Hazards
2
Mental Health
2
Zika
1
В этих новых руководящих принципах рекомендуется использовать упрощенный алгоритм скрининга, основанного на четырех клинических симптомах, для выявления
...
В помощь руководи*телям и практикующим врачам приведены конкретные меры, направ*ленные на улучшение медицинской помощи и обеспечение равногодоступа к не
...
Цель настоящего документа («Основные положения») заключается в подготовке рекомендаций относительно необходимых на национальном уровне мер по адаптации стратег
...
В настоящем отчете (это уже четвертое его издание) анализируются препятствия и факторы, затрудняющие доступ к препаратам для лечения лекарственно-устойчивого туб
...
The pre-clinical pipeline shows more innovation and diversity, with 252 agents being developed to treat WHO priority pathogens.
However, these products are in the very early stages of development and still need to be proven effective and safe. The optimistic scenario, the report indicates, is for
...
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr
...
The Antimicrobial Resistance Benchmark has evaluated for the second time how the most important players in the antibiotic market are addressing the rise of resistance and the global need for appropriate access to antibiotics. Although we can see progress — it’s hanging by a thread.
We have reac
...
Integrated Management of Adolescent and Adult Illness (IMAI)
July 2008
Healthcare-associated infections (HAI) are a significant burden globally, with millions of patients affected each year. These infections affect both high- and limited-resource healthcare settings, but in limited-resource settings, rates are approximately twice as high as high-resource settings (15 o
...
This document provides guidance on how to implement contact screening and chemoprophylaxis with single-dose rifampicin. The contents are logically ordered: counselling and obtaining consent, identification and listing of index case, listing of contacts, tracing of contacts, screening of contacts, ad
...
Ce guide sur la tuberculose résistante est un outil pratique destiné à aider les agents de santé à prendre en charge le malade du point de vue clinique et opérationnel en mettant l’accent sur la décision thérapeutique, la mise en œuvre et le suivi du régime court de 9 mois pour le traite
...
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral regimen for the treatment of MDR/RR-TB.
This Ra
...
2ª edição atualizada.
O Manual de Recomendações apresenta as diretrizes nacionais para o controle da doença, que incluem procedimentos clínicos padronizados, procedimentos laboratoriais, sistema de vigilância, ações de biossegurança e organização de serviços. Apesar de conter as reco
...
Rev Mex Patol Clin Med Lab 2020; 67 (2): 93-112: La tuberculosis (TB) es en la actualidad la patología de tipo infeccioso que causa mayor número de muertes alrededor del mundo cada año. La percepción acerca de esta entidad ha cambiado a lo largo del tiempo, ya que se consideraba que se relaciona
...
Acta Med Peru. 2017;34(3):182-7; El objetivo del presente trabajo es conocer la magnitud del problema de la TB y sus principales características epidemiológicas en la población del penal de varones de penal de varones de Trujillo, que sirva de base para plantear las mejores soluciones terapéutic
...
